GSK
Stock Forecast, Prediction & Price Target
GSK Financial Estimates
GSK Revenue Estimates
GSK EBITDA Estimates
GSK Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| £34.11B N/A | £29.32B -14.04% | £30.32B 3.42% | Avg: £33.63B Low: £33.63B High: £33.63B avg. 10.91% | Avg: £35.59B Low: £35.59B High: £35.59B avg. 5.80% | Avg: £37.22B Low: £37.22B High: £37.22B avg. 4.59% | Avg: £37.42B Low: £37.42B High: £37.42B avg. 0.52% |
Net Income
% change YoY
| £4.38B N/A | £4.92B 12.22% | £4.92B 0.14% | Avg: £6.49B Low: £5.96B High: £7.05B avg. 31.72% | Avg: £7.15B Low: £6.66B High: £7.78B avg. 10.22% | Avg: £8.77B Low: £8.77B High: £8.77B avg. 22.60% | Avg: £8.79B Low: £8.79B High: £8.79B avg. 0.20% |
EBITDA
% change YoY
| £8.78B N/A | £8.80B 0.21% | £9.13B 3.78% | Avg: £9.50B Low: £9.50B High: £9.50B avg. 4.02% | Avg: £10.05B Low: £10.05B High: £10.05B avg. 5.80% | Avg: £10.51B Low: £10.51B High: £10.51B avg. 4.59% | Avg: £10.57B Low: £10.57B High: £10.57B avg. 0.52% |
EPS
% change YoY
| $1.37 N/A | $1.22 -10.94% | $1.22 0% | Avg: $1.58 Low: $1.45 High: $1.72 avg. 29.60% | Avg: $1.75 Low: $1.62 High: $1.89 avg. 10.41% | Avg: $2.13 Low: $2.13 High: $2.13 avg. 22.23% | Avg: $2.14 Low: $2.14 High: $2.14 avg. 0.20% |
Operating Expenses
% change YoY
| £16.31B N/A | £13.33B -18.22% | £15.01B 12.60% | Avg: £10.61B Low: £10.61B High: £10.61B avg. -29.29% | Avg: £11.23B Low: £11.23B High: £11.23B avg. 5.80% | Avg: £11.74B Low: £11.74B High: £11.74B avg. 4.59% | Avg: £11.81B Low: £11.81B High: £11.81B avg. 0.52% |
FAQ
What is GSK stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.19% in 2025-2028.
We have gathered data from 11 analysts. Their low estimate is 5.96B, average is 6.49B and high is 7.05B.
What is GSK stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5.45% in 2025-2028.
We have gathered data from 21 analysts. Their low revenue estimate is £33.63B, average is £33.63B and high is £33.63B.
What is GSK stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.61% in 2025-2028.
We have gathered data from 11 analysts. Their low earnings per share estimate is $1.45, average is $1.58 and high is £1.71.